Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaPaul G. Richardson, Kenneth C. Anderson, David Avigan et al.|Blood|2010Cited by 866
Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II StudyPaul G. Richardson, Kenneth C. Anderson, Sagar Lonial et al.|Blood|2008Cited by 68
A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.MV Mateos, Jesús F. San Miguel, Joan Bladé et al.|Blood|2004Cited by 39